Microtubule-targeted agents: When mitochondria become essential to chemotherapy

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1807, Issue 6, 2011, Pages 679-688

  Rovini, A ^a   Savry, A ^a,b   Braguer, D ^a,b   Carre M ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Anticancer drug; Apoptosis; Microtubule; Mitochondria; Pharmacology

Indexed keywords

CASPASE 3; CASPASE 9; CYCLOSPORIN; DOCETAXEL; DYNEIN ADENOSINE TRIPHOSPHATASE; EPOTHILONE A; EPOTHILONE B; IXABEPILONE; MICROTUBULE ASSOCIATED PROTEIN; NAVELBINE; NOCODAZOLE; OBLIMERSEN; OLESOXIME; PACLITAXEL; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VINCRISTINE; VINFLUNINE;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; DISEASE COURSE; DRUG EFFICACY; HUMAN; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MEMBRANE PERMEABILITY; MICROTUBULE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SPINAL GANGLION; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; MICROTUBULES; MITOCHONDRIA; NEOPLASMS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 79955575758     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2011.01.001     Document Type: Review

References (195)

1. T. Mitchison, and M. Kirschner Dynamic instability of microtubule growth Nature 312 1984 237 242 (Pubitemid 15201998)
2. E. Pasquier, N. Andre, and D. Braguer Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment Curr. Cancer Drug Targets 7 2007 566 581 (Pubitemid 47358143)
3. D. Calligaris, P. Verdier-Pinard, F. Devred, C. Villard, D. Braguer, and D. Lafitte Microtubule targeting agents: from biophysics to proteomics Cell. Mol. Life Sci. 67 2010 1089 1104
4. S.M. Chen, L.H. Meng, and J. Ding New microtubule-inhibiting anticancer agents Expert Opin. Investig. Drugs 19 2010 329 343
5. F. Petrelli, K. Borgonovo, and S. Barni Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel Expert Opin. Pharmacother. 11 2010 1413 1432
6. E.A. Perez Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance Mol. Cancer Ther. 8 2009 2086 2095
7. L. Wilson, and M.A. Jordan New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies J. Chemother. 16 Suppl 4 2004 83 85 (Pubitemid 40065290)
8. S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M.A. Jordan Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation Mol. Cancer Ther. 2 2003 1303 1311
9. S. Honore, E. Pasquier, and D. Braguer Understanding microtubule dynamics for improved cancer therapy Cell. Mol. Life Sci. 62 2005 3039 3056 (Pubitemid 43004753)
10. K. Kamath, and M.A. Jordan Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest Cancer Res. 63 2003 6026 6031 (Pubitemid 37187506)
11. B. Pourroy, S. Honore, E. Pasquier, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells Cancer Res. 66 2006 3256 3263
12. C.L. Rieder, and H. Maiato Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint Dev. Cell 7 2004 637 651 (Pubitemid 39462685)
13. S. Honore, K. Kamath, D. Braguer, S.B. Horwitz, L. Wilson, C. Briand, and M.A. Jordan Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells Cancer Res. 64 2004 4957 4964 (Pubitemid 38924543)
14. V.K. Ngan, K. Bellman, B.T. Hill, L. Wilson, and M.A. Jordan Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine Mol. Pharmacol. 60 2001 225 232 (Pubitemid 32595250)
15. B. Pourroy, M. Carre, S. Honore, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway Mol. Pharmacol. 66 2004 580 591 (Pubitemid 39329257)
16. M.E. Bekier, R. Fischbach, J. Lee, and W.R. Taylor Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit Mol. Cancer Ther. 8 2009 1646 1654
17. M.A. Esteve, M. Carre, V. Bourgarel-Rey, A. Kruczynski, G. Raspaglio, C. Ferlini, and D. Braguer Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine Mol. Cancer Ther. 5 2006 2824 2833 (Pubitemid 44849009)
18. G. Liao, T. Nagasaki, and G.G. Gundersen Low concentrations of nocodazole interfere with fibroblast locomotion without significantly affecting microtubule level: implications for the role of dynamic microtubules in cell locomotion J. Cell Sci. 108 Pt 11 1995 3473 3483
19. A. Mikhailov, and G.G. Gundersen Relationship between microtubule dynamics and lamellipodium formation revealed by direct imaging of microtubules in cells treated with nocodazole or taxol Cell Motil. Cytoskeleton 41 1998 325 340 (Pubitemid 29086468)
20. E. Pasquier, S. Honore, B. Pourroy, M.A. Jordan, M. Lehmann, C. Briand, and D. Braguer Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells Cancer Res. 65 2005 2433 2440 (Pubitemid 40490155)
21. S. Honore, A. Pagano, G. Gauthier, V. Bourgarel-Rey, P. Verdier-Pinard, K. Civiletti, A. Kruczynski, and D. Braguer Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites Mol. Cancer Ther. 7 2008 2080 2089
22. A. Akhmanova, and M.O. Steinmetz Tracking the ends: a dynamic protein network controls the fate of microtubule tips Nat. Rev. Mol. Cell Biol. 9 2008 309 322 (Pubitemid 351430849)
23. A. Rovini, M. Carre, T. Bordet, R.M. Pruss, and D. Braguer Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells Biochem. Pharmacol. 80 2010 884 894
24. D. Simoni, R. Romagnoli, R. Baruchello, R. Rondanin, M. Rizzi, M.G. Pavani, D. Alloatti, G. Giannini, M. Marcellini, T. Riccioni, M. Castorina, M.B. Guglielmi, F. Bucci, P. Carminati, and C. Pisano Novel combretastatin analogues endowed with antitumor activity J. Med. Chem. 49 2006 3143 3152 (Pubitemid 43830513)
25. K.D. Wu, Y.S. Cho, J. Katz, V. Ponomarev, S. Chen-Kiang, S.J. Danishefsky, and M.A. Moore Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo Proc. Natl Acad. Sci. USA 102 2005 10640 10645 (Pubitemid 41061607)
26. C. Rappl, P. Barbier, V. Bourgarel-Rey, C. Gregoire, R. Gilli, M. Carre, S. Combes, J.P. Finet, and V. Peyrot Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin Biochemistry 45 2006 9210 9218 (Pubitemid 44156384)
27. M.A. Esteve, M. Carre, and D. Braguer Microtubules in apoptosis induction: are they necessary? Curr. Cancer Drug Targets 7 2007 713 729
28. B. Lin, L. Catley, R. LeBlanc, C. Mitsiades, R. Burger, Y.T. Tai, K. Podar, M. Wartmann, D. Chauhan, J.D. Griffin, and K.C. Anderson Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo Blood 105 2005 350 357 (Pubitemid 40053103)
29. K. Bhalla, A.M. Ibrado, E. Tourkina, C. Tang, M.E. Mahoney, and Y. Huang Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells Leukemia 7 1993 563 568 (Pubitemid 23139860)
30. E. Pasquier, M. Carre, B. Pourroy, L. Camoin, O. Rebai, C. Briand, and D. Braguer Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway Mol. Cancer Ther. 3 2004 1301 1310 (Pubitemid 39440174)
31. S.E. Holwell, B.T. Hill, and M.C. Bibby Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model Br. J. Cancer 84 2001 290 295 (Pubitemid 32113459)
32. A. Goncalves, D. Braguer, G. Carles, N. Andre, C. Prevot, and C. Briand Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4) Biochem. Pharmacol. 60 2000 1579 1584
33. R. Kim, K. Tanabe, M. Emi, Y. Uchida, and T. Toge Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells Oncol. Rep. 10 2003 1925 1930
34. S. Fulda, and K.M. Debatin Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy Oncogene 25 2006 4798 4811 (Pubitemid 44187627)
35. N. Andre, M. Carre, G. Brasseur, B. Pourroy, H. Kovacic, C. Briand, and D. Braguer Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells FEBS Lett. 532 2002 256 260 (Pubitemid 35375900)
36. S. Jiang, Y. Zu, Y. Fu, Y. Zhang, and T. Efferth Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel Int. J. Oncol. 33 2008 103 111
37. 2 Langmuir 24 2008 7432 7441
38. S.D. Patterson, C.S. Spahr, E. Daugas, S.A. Susin, T. Irinopoulou, C. Koehler, and G. Kroemer Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition Cell Death Differ. 7 2000 137 144 (Pubitemid 30150781)
39. G. Van Loo, H. Demol, M. van Gurp, B. Hoorelbeke, P. Schotte, R. Beyaert, B. Zhivotovsky, K. Gevaert, W. Declercq, J. Vandekerckhove, and P. Vandenabeele A matrix-assisted laser desorption ionization post-source decay (MALDI-PSD) analysis of proteins released from isolated liver mitochondria treated with recombinant truncated Bid Cell Death Differ. 9 2002 301 308 (Pubitemid 34223873)
40. A. Kruczynski, C. Etievant, D. Perrin, N. Chansard, A. Duflos, and B.T. Hill Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development Br. J. Cancer 86 2002 143 150 (Pubitemid 34146355)
41. S.J. Park, C.H. Wu, J.D. Gordon, X. Zhong, A. Emami, and A.R. Safa Taxol induces caspase-10-dependent apoptosis J. Biol. Chem. 279 2004 51057 51067 (Pubitemid 40017847)
42. C.L. Perkins, G. Fang, C.N. Kim, and K.N. Bhalla The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis Cancer Res. 60 2000 1645 1653 (Pubitemid 30183437)
43. S.Y. Yuan, S.L. Hsu, K.J. Tsai, and C.R. Yang Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells Urol. Res. 30 2002 282 288
44. D. Uyar, N. Takigawa, T. Mekhail, D. Grabowski, M. Markman, F. Lee, R. Canetta, R. Peck, R. Bukowski, and R. Ganapathi Apoptotic pathways of epothilone BMS 310705 Gynecol. Oncol. 91 2003 173 178 (Pubitemid 37188608)
45. C. Perkins, C.N. Kim, G. Fang, and K.N. Bhalla Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells Cancer Res. 58 1998 4561 4566 (Pubitemid 28480614)
46. K. Friedrich, T. Wieder, C. Von Haefen, S. Radetzki, R. Janicke, K. Schulze-Osthoff, B. Dorken, and P.T. Daniel Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance Oncogene 20 2001 2749 2760 (Pubitemid 32549832)
47. J. Chai, C. Du, J.W. Wu, S. Kyin, X. Wang, and Y. Shi Structural and biochemical basis of apoptotic activation by Smac/DIABLO Nature 406 2000 855 862 (Pubitemid 30664254)
48. T.E. Fandy, S. Shankar, and R.K. Srivastava Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells Mol. Cancer 7 2008 60
49. C.R. Arnt, M.V. Chiorean, M.P. Heldebrant, G.J. Gores, and S.H. Kaufmann Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ J. Biol. Chem. 277 2002 44236 44243 (Pubitemid 36157856)
50. I.A. McNeish, S. Bell, T. McKay, T. Tenev, M. Marani, and N.R. Lemoine Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway Exp. Cell Res. 286 2003 186 198 (Pubitemid 36566432)
51. H.L. Mao, P.S. Liu, J.F. Zheng, P.H. Zhang, L.G. Zhou, G. Xin, and C. Liu Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro Pharmacol. Res. 56 2007 483 492 (Pubitemid 350137770)
52. L.D. Walensky BCL-2 in the crosshairs: tipping the balance of life and death Cell Death Differ. 13 2006 1339 1350 (Pubitemid 44057469)
53. N.A. Jones, J. Turner, A.J. McIlwrath, R. Brown, and C. Dive Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53 Mol. Pharmacol. 53 1998 819 826 (Pubitemid 28244068)
54. H. Yamaguchi, J. Chen, K. Bhalla, and H.G. Wang Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways J. Biol. Chem. 279 2004 39431 39437 (Pubitemid 39258208)
55. G. Tudor, A. Aguilera, D.O. Halverson, N.D. Laing, and E.A. Sausville Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels Cell Death Differ. 7 2000 574 586 (Pubitemid 30303613)
56. T. Strobel, Y.T. Tai, S. Korsmeyer, and S.A. Cannistra BAD partly reverses paclitaxel resistance in human ovarian cancer cells Oncogene 17 1998 2419 2427 (Pubitemid 28544711)
57. H. Sawa, T. Kobayashi, K. Mukai, W. Zhang, and H. Shiku Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis Int. J. Oncol. 16 2000 745 749
58. V.N. Sumantran, M.W. Ealovega, G. Nunez, M.F. Clarke, and M.S. Wicha Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis Cancer Res. 55 1995 2507 2510
59. G.W. Makin, B.M. Corfe, G.J. Griffiths, A. Thistlethwaite, J.A. Hickman, and C. Dive Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate EMBO J. 20 2001 6306 6315 (Pubitemid 33078704)
60. B. Antonsson, S. Montessuit, B. Sanchez, and J.C. Martinou Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells J. Biol. Chem. 276 2001 11615 11623
61. P.F. Cartron, M. Priault, L. Oliver, K. Meflah, S. Manon, and F.M. Vallette The N-terminal end of Bax contains a mitochondrial-targeting signal J. Biol. Chem. 278 2003 11633 11641 (Pubitemid 36792725)
62. D. Griffin, S. Wittmann, F. Guo, R. Nimmanapalli, P. Bali, H.G. Wang, and K. Bhalla Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells Gynecol. Oncol. 89 2003 37 47 (Pubitemid 36403645)
63. C. Huisman, C.G. Ferreira, L.E. Broker, J.A. Rodriguez, E.F. Smit, P.E. Postmus, F.A. Kruyt, and G. Giaccone Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460 Clin. Cancer Res. 8 2002 596 606 (Pubitemid 34193982)
64. L. Du, C.S. Lyle, and T.C. Chambers Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction Oncogene 24 2005 107 117 (Pubitemid 40143870)
65. N. Pathan, C. Aime-Sempe, S. Kitada, S. Haldar, and J.C. Reed Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1 Neoplasia 3 2001 70 79 (Pubitemid 32201612)
66. S. Haldar, J. Chintapalli, and C.M. Croce Taxol induces bcl-2 phosphorylation and death of prostate cancer cells Cancer Res. 56 1996 1253 1255 (Pubitemid 26080965)
67. L. Brichese, and A. Valette PP1 phosphatase is involved in Bcl-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel Biochem. Biophys. Res. Commun. 294 2002 504 508 (Pubitemid 34694122)
68. C.D. Scatena, Z.A. Stewart, D. Mays, L.J. Tang, C.J. Keefer, S.D. Leach, and J.A. Pietenpol Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest J. Biol. Chem. 273 1998 30777 30784 (Pubitemid 28545562)
69. M. Fan, L. Du, A.A. Stone, K.M. Gilbert, and T.C. Chambers Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1 Cancer Res. 60 2000 6403 6407
70. T.A. Buchholz, D.W. Davis, D.J. McConkey, W.F. Symmans, V. Valero, A. Jhingran, S.L. Tucker, L. Pusztai, M. Cristofanilli, F.J. Esteva, G.N. Hortobagyi, and A.A. Sahin Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy Cancer J. 9 2003 33 41
71. C. Bressin, V. Bourgarel-Rey, M. Carre, B. Pourroy, D. Arango, D. Braguer, and Y. Barra Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine Anticancer Drugs 17 2006 181 187
72. M.L. Panno, F. Giordano, F. Mastroianni, C. Morelli, E. Brunelli, M.G. Palma, M. Pellegrino, S. Aquila, A. Miglietta, L. Mauro, D. Bonofiglio, and S. Ando Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells FEBS Lett. 580 2006 2371 2380
73. T. Yoshino, H. Shiina, S. Urakami, N. Kikuno, T. Yoneda, K. Shigeno, and M. Igawa Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy Clin. Cancer Res. 12 2006 6116 6124 (Pubitemid 44703777)
74. I. Lebedeva, R. Rando, J. Ojwang, P. Cossum, and C.A. Stein Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity Cancer Res. 60 2000 6052 6060
75. X. Tang, Y. Zhu, L. Han, A.L. Kim, L. Kopelovich, D.R. Bickers, and M. Athar CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice J. Clin. Invest. 117 2007 3753 3764 (Pubitemid 350224086)
76. J. Hoffmann, I. Vitale, B. Buchmann, L. Galluzzi, W. Schwede, L. Senovilla, W. Skuballa, S. Vivet, R.B. Lichtner, J.M. Vicencio, T. Panaretakis, G. Siemeister, H. Lage, L. Nanty, S. Hammer, K. Mittelstaedt, S. Winsel, J. Eschenbrenner, M. Castedo, C. Demarche, U. Klar, and G. Kroemer Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone Cancer Res. 68 2008 5301 5308
77. C. Leonetti, A. Biroccio, C. D'Angelo, S.C. Semple, M. Scarsella, and G. Zupi Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer Prostate 67 2007 1475 1485 (Pubitemid 47435794)
78. K. Tanabe, R. Kim, H. Inoue, M. Emi, Y. Uchida, and T. Toge Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs Int. J. Oncol. 22 2003 875 881
79. K. Yamanaka, P. Rocchi, H. Miyake, L. Fazli, A. So, U. Zangemeister-Wittke, and M.E. Gleave Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes BJU Int. 97 2006 1300 1308 (Pubitemid 43907340)
80. O. Kutuk, and A. Letai Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737 Cancer Res. 68 2008 7985 7994
81. T. Oltersdorf, S.W. Elmore, A.R. Shoemaker, R.C. Armstrong, D.J. Augeri, B.A. Belli, M. Bruncko, T.L. Deckwerth, J. Dinges, P.J. Hajduk, M.K. Joseph, S. Kitada, S.J. Korsmeyer, A.R. Kunzer, A. Letai, C. Li, M.J. Mitten, D.G. Nettesheim, S. Ng, P.M. Nimmer, J.M. O'Connor, A. Oleksijew, A.M. Petros, J.C. Reed, W. Shen, S.K. Tahir, C.B. Thompson, K.J. Tomaselli, B. Wang, M.D. Wendt, H. Zhang, S.W. Fesik, and S.H. Rosenberg An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435 2005 677 681 (Pubitemid 40825512)
82. H. Zall, A. Weber, R. Besch, N. Zantl, and G. Hacker Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1 Mol. Cancer 9 2010 164
83. A.R. Shoemaker, A. Oleksijew, J. Bauch, B.A. Belli, T. Borre, M. Bruncko, T. Deckwirth, D.J. Frost, K. Jarvis, M.K. Joseph, K. Marsh, W. McClellan, H. Nellans, S. Ng, P. Nimmer, J.M. O'Connor, T. Oltersdorf, W. Qing, W. Shen, J. Stavropoulos, S.K. Tahir, B. Wang, R. Warner, H. Zhang, S.W. Fesik, S.H. Rosenberg, and S.W. Elmore A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo Cancer Res. 66 2006 8731 8739 (Pubitemid 44449190)
84. K. Bray, H.Y. Chen, C.M. Karp, M. May, S. Ganesan, V. Karantza-Wadsworth, R.S. DiPaola, and E. White Bcl-2 modulation to activate apoptosis in prostate cancer Mol. Cancer Res. 7 2009 1487 1496
85. A.A. Chanan-Khan, R. Niesvizky, R.J. Hohl, T.M. Zimmerman, N.P. Christiansen, G.J. Schiller, N. Callander, J. Lister, M. Oken, and S. Jagannath Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma Leuk. Lymphoma 50 2009 559 565
86. S. O'Brien, J.O. Moore, T.E. Boyd, L.M. Larratt, A. Skotnicki, B. Koziner, A.A. Chanan-Khan, J.F. Seymour, R.G. Bociek, S. Pavletic, and K.R. Rai Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia J. Clin. Oncol. 25 2007 1114 1120 (Pubitemid 46596764)
87. E. Wesarg, S. Hoffarth, R. Wiewrodt, M. Kroll, S. Biesterfeld, C. Huber, and M. Schuler Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer Int. J. Cancer 121 2007 2387 2394 (Pubitemid 350022407)
88. C. Ferlini, G. Raspaglio, S. Mozzetti, M. Distefano, F. Filippetti, E. Martinelli, G. Ferrandina, D. Gallo, F.O. Ranelletti, and G. Scambia Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance Mol. Pharmacol. 64 2003 51 58 (Pubitemid 36759817)
89. Y. Inoue, M. Gika, T. Abiko, T. Oyama, Y. Saitoh, H. Yamazaki, M. Nakamura, Y. Abe, M. Kawamura, and K. Kobayashi Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer Oncol. Rep. 13 2005 259 264
90. M. Vilenchik, A.J. Raffo, L. Benimetskaya, D. Shames, and C.A. Stein Antisense RNA down-regulation of bcl-xL expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents Cancer Res. 62 2002 2175 2183 (Pubitemid 34408468)
91. K. Vermeulen, Z.N. Berneman, and D.R. Van Bockstaele Cell cycle and apoptosis Cell Prolif. 36 2003 165 175 (Pubitemid 36808272)
92. P. Giannakakou, D.L. Sackett, Y. Ward, K.R. Webster, M.V. Blagosklonny, and T. Fojo p53 is associated with cellular microtubules and is transported to the nucleus by dynein Nat. Cell Biol. 2 2000 709 717
93. N.R. Khawaja, M. Carre, H. Kovacic, M.A. Esteve, and D. Braguer Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria Mol. Pharmacol. 74 2008 1072 1083
94. X.M. Liu, J.D. Jiang, A.C. Ferrari, D.R. Budman, and L.G. Wang Unique induction of p21(WAF1/CIP1) expression by vinorelbine in androgen-independent prostate cancer cells Br. J. Cancer 89 2003 1566 1573 (Pubitemid 37386616)
95. K. Rathinasamy, B. Jindal, J. Asthana, P. Singh, P.V. Balaji, and D. Panda Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine BMC Cancer 10 2010 213
96. R.B. Tishler, D.M. Lamppu, S. Park, and B.D. Price Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53 Cancer Res. 55 1995 6021 6025
97. H.H. Wang, H.L. Li, R. Liu, Y. Zhang, K. Liao, Q. Wang, J.Z. Wang, and S.J. Liu Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors J. Alzheimers Dis. 2010 167 179
98. R. Drago-Ferrante, A. Santulli, R. Di Fiore, M. Giuliano, G. Calvaruso, G. Tesoriere, and R. Vento Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1 Int. J. Oncol. 33 2008 677 687
99. T.T. Tan, K. Degenhardt, D.A. Nelson, B. Beaudoin, W. Nieves-Neira, P. Bouillet, A. Villunger, J.M. Adams, and E. White Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy Cancer Cell 7 2005 227 238 (Pubitemid 40568682)
100. M.D. Galigniana, J.M. Harrell, H.M. O'Hagen, M. Ljungman, and W.B. Pratt Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus J. Biol. Chem. 279 2004 22483 22489 (Pubitemid 38679447)
101. K. Rathinasamy, and D. Panda Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53 Biochem. Pharmacol. 76 2008 1669 1680
102. A. Basu, and S. Haldar The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death Mol. Hum. Reprod. 4 1998 1099 1109 (Pubitemid 28552792)
103. Y. Wu, J.W. Mehew, C.A. Heckman, M. Arcinas, and L.M. Boxer Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene 20 2001 240 251 (Pubitemid 32150269)
104. V. Bourgarel-Rey, A. Savry, G. Hua, M. Carre, C. Bressin, C. Chacon, J. Imbert, D. Braguer, and Y. Barra Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter Biochem. Pharmacol. 78 2009 1148 1156
105. P. Giannakakou, R. Robey, T. Fojo, and M.V. Blagosklonny Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity Oncogene 20 2001 3806 3813 (Pubitemid 32646191)
106. J. Han, C. Flemington, A.B. Houghton, Z. Gu, G.P. Zambetti, R.J. Lutz, L. Zhu, and T. Chittenden Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals Proc. Natl Acad. Sci. USA 98 2001 11318 11323 (Pubitemid 32928726)
107. K. Nakano, and K.H. Vousden PUMA, a novel proapoptotic gene, is induced by p53 Mol. Cell 7 2001 683 694 (Pubitemid 32706359)
108. G. Achanta, R. Sasaki, L. Feng, J.S. Carew, W. Lu, H. Pelicano, M.J. Keating, and P. Huang Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma EMBO J. 24 2005 3482 3492 (Pubitemid 41486785)
109. S. Erster, and U.M. Moll Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo Cell Cycle 3 2004 1492 1495 (Pubitemid 40521398)
110. M. Mihara, S. Erster, A. Zaika, O. Petrenko, T. Chittenden, P. Pancoska, and U.M. Moll p53 has a direct apoptogenic role at the mitochondria Mol. Cell 11 2003 577 590 (Pubitemid 36385115)
111. C. Sansome, A. Zaika, N.D. Marchenko, and U.M. Moll Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells FEBS Lett. 488 2001 110 115 (Pubitemid 32103581)
112. N.D. Marchenko, A. Zaika, and U.M. Moll Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling J. Biol. Chem. 275 2000 16202 16212 (Pubitemid 30366932)
113. Y. Zhao, L. Chaiswing, J.M. Velez, I. Batinic-Haberle, N.H. Colburn, T.D. Oberley, and D.K. St Clair p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase Cancer Res. 65 2005 3745 3750 (Pubitemid 40616352)
114. D.R. Green, and G. Kroemer Cytoplasmic functions of the tumour suppressor p53 Nature 458 2009 1127 1130
115. E. Strom, S. Sathe, P.G. Komarov, O.B. Chernova, I. Pavlovska, I. Shyshynova, D.A. Bosykh, L.G. Burdelya, R.M. Macklis, R. Skaliter, E.A. Komarova, and A.V. Gudkov Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation Nat. Chem. Biol. 2 2006 474 479 (Pubitemid 44266309)
116. N. Corazza, S. Jakob, C. Schaer, S. Frese, A. Keogh, D. Stroka, D. Kassahn, R. Torgler, C. Mueller, P. Schneider, and T. Brunner TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality J. Clin. Invest. 116 2006 2493 2499 (Pubitemid 44330148)
117. D.B. Costa, B. Halmos, A. Kumar, S.T. Schumer, M.S. Huberman, T.J. Boggon, D.G. Tenen, and S. Kobayashi BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations PLoS Med. 4 2007 1669 1679 discussion 1680
118. J. Kuroda, H. Puthalakath, M.S. Cragg, P.N. Kelly, P. Bouillet, D.C. Huang, S. Kimura, O.G. Ottmann, B.J. Druker, A. Villunger, A.W. Roberts, and A. Strasser Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic Proc. Natl Acad. Sci. USA 103 2006 14907 14912 (Pubitemid 44527827)
119. J. Lu, B. Quearry, and H. Harada p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells FEBS Lett. 580 2006 3539 3544 (Pubitemid 44208999)
120. A. Nordigarden, M. Kraft, P. Eliasson, V. Labi, E.W. Lam, A. Villunger, and J.I. Jonsson BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3 Blood 113 2009 2302 2311
121. S.N. Willis, and J.M. Adams Life in the balance: how BH3-only proteins induce apoptosis Curr. Opin. Cell Biol. 17 2005 617 625 (Pubitemid 41540411)
122. A. Sunters, S. Fernandez de Mattos, M. Stahl, J.J. Brosens, G. Zoumpoulidou, C.A. Saunders, P.J. Coffer, R.H. Medema, R.C. Coombes, and E.W. Lam FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines J. Biol. Chem. 278 2003 49795 49805 (Pubitemid 37548813)
123. D. Li, and M.B. Sewer RhoA and diaphanous-related homolog 1 mediate adrenocorticotropin-stimulated cortisol biosynthesis by regulating mitochondrial trafficking Endocrinology 2010 247 258
124. P. Bouillet, D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Kontgen, J.M. Adams, and A. Strasser Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity Science 286 1999 1735 1738 (Pubitemid 129515880)
125. D. Chen, and Q. Zhou Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling Proc. Natl Acad. Sci. USA 101 2004 1235 1240 (Pubitemid 38182672)
126. H. Puthalakath, D.C. Huang, L.A. O'Reilly, S.M. King, and A. Strasser The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex Mol. Cell 3 1999 287 296 (Pubitemid 29290669)
127. D. Chen, M. Wang, S. Zhou, and Q. Zhou HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim EMBO J. 21 2002 6801 6810 (Pubitemid 36014552)
128. A.J. Butt, C.G. Roberts, A.A. Seawright, P.B. Oelrichs, J.K. Macleod, T.Y. Liaw, M. Kavallaris, T.J. Somers-Edgar, G.M. Lehrbach, C.K. Watts, and R.L. Sutherland A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells Mol. Cancer Ther. 5 2006 2300 2309 (Pubitemid 44530467)
129. C. Cenciarelli, C. Tanzarella, I. Vitale, C. Pisano, P. Crateri, S. Meschini, G. Arancia, and A. Antoccia The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460 Apoptosis 13 2008 659 669
130. U.M. Schneiders, L. Schyschka, A. Rudy, and A.M. Vollmar BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells Mol. Cancer Ther. 8 2009 2914 2925
131. K. Lei, and R.J. Davis JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis Proc. Natl Acad. Sci. USA 100 2003 2432 2437 (Pubitemid 36297516)
132. T. Tong, J. Ji, S. Jin, X. Li, W. Fan, Y. Song, M. Wang, Z. Liu, M. Wu, and Q. Zhan Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria Mol. Cell. Biol. 25 2005 4488 4500 (Pubitemid 40705755)
133. J. Alexandre, F. Batteux, C. Nicco, C. Chereau, A. Laurent, L. Guillevin, B. Weill, and F. Goldwasser Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo Int. J. Cancer 119 2006 41 48
134. H. Fawcett, J.S. Mader, M. Robichaud, C. Giacomantonio, and D.W. Hoskin Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells Int. J. Oncol. 27 2005 1717 1726
135. H.L. Lin, T.Y. Liu, G.Y. Chau, W.Y. Lui, and C.W. Chi Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species Cancer 89 2000 983 994
136. G. Varbiro, B. Veres, F. Gallyas Jr., and B. Sumegi Direct effect of Taxol on free radical formation and mitochondrial permeability transition Free Radic. Biol. Med. 31 2001 548 558 (Pubitemid 32728442)
137. C.M. Khawaja NR, B. Pourroy, H. Kovacic, and D. Braguer High potency of epothilones in neuroblastoma cells may involve mitochondria American Association for Cancer Research (AACR) Meeting Abstracts 2006
138. N. Andre, D. Braguer, G. Brasseur, A. Goncalves, D. Lemesle-Meunier, S. Guise, M.A. Jordan, and C. Briand Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells Cancer Res. 60 2000 5349 5353
139. S.L. Mironov, M.V. Ivannikov, and M. Johansson [Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release J. Biol. Chem. 280 2005 715 721 (Pubitemid 40165039)
140. J.F. Kidd, M.F. Pilkington, M.J. Schell, K.E. Fogarty, J.N. Skepper, C.W. Taylor, and P. Thorn Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore J. Biol. Chem. 277 2002 6504 6510 (Pubitemid 34968448)
141. G.G. D'Souza, S.M. Cheng, S.V. Boddapati, R.W. Horobin, and V. Weissig Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel J. Drug Target. 16 2008 578 585
142. M. Carre, N. Andre, G. Carles, H. Borghi, L. Brichese, C. Briand, and D. Braguer Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel J. Biol. Chem. 277 2002 33664 33669
143. M. Carre, G. Carles, N. Andre, S. Douillard, J. Ciccolini, C. Briand, and D. Braguer Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis Biochem. Pharmacol. 63 2002 1831 1842 (Pubitemid 34603447)
144. L. Cicchillitti, R. Penci, M. Di Michele, F. Filippetti, D. Rotilio, M.B. Donati, G. Scambia, and C. Ferlini Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin Mol. Cancer Ther. 7 2008 2070 2079
145. T.K. Rostovtseva, K.L. Sheldon, E. Hassanzadeh, C. Monge, V. Saks, S.M. Bezrukov, and D.L. Sackett Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration Proc. Natl Acad. Sci. USA 105 2008 18746 18751
146. Y.V. Evtodienko, V.V. Teplova, S.S. Sidash, F. Ichas, and J.P. Mazat Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria FEBS Lett. 393 1996 86 88 (Pubitemid 26298235)
147. D.J. Rodi, R.W. Janes, H.J. Sanganee, R.A. Holton, B.A. Wallace, and L. Makowski Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein J. Mol. Biol. 285 1999 197 203 (Pubitemid 29034037)
148. J.H. Wu, G. Batist, and L.O. Zamir A model for the interaction of paclitaxel with the Bcl-2 loop domain: a chemical approach to induce conformation-dependent phosphorylation Anticancer Drug Des. 15 2000 441 446 (Pubitemid 32762370)
149. C. Ferlini, L. Cicchillitti, G. Raspaglio, S. Bartollino, S. Cimitan, C. Bertucci, S. Mozzetti, D. Gallo, M. Persico, C. Fattorusso, G. Campiani, and G. Scambia Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77 Cancer Res. 69 2009 6906 6914
150. L. Knipling, and J. Wolff Direct interaction of Bcl-2 proteins with tubulin Biochem. Biophys. Res. Commun. 341 2006 433 439 (Pubitemid 43152123)
151. J.W. Smyth, T.T. Hong, D. Gao, J.M. Vogan, B.C. Jensen, T.S. Fong, P.C. Simpson, D.Y. Stainier, N.C. Chi, and R.M. Shaw Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium J. Clin. Invest. 120 2010 266 279
152. C. Sioka, and A.P. Kyritsis Central and peripheral nervous system toxicity of common chemotherapeutic agents Cancer Chemother. Pharmacol. 63 2009 761 767
153. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies Eur. J. Cancer 44 2008 1507 1515
154. F.H. Hausheer, R.L. Schilsky, S. Bain, E.J. Berghorn, and F. Lieberman Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy Semin. Oncol. 33 2006 15 49 (Pubitemid 43214485)
155. T. Bordet, and R.M. Pruss Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain Neurotherapeutics 6 2009 648 662
156. T.J. Kaley, and L.M. Deangelis Therapy of chemotherapy-induced peripheral neuropathy Br. J. Haematol. 145 2009 3 14
157. N. Authier, D. Balayssac, F. Marchand, B. Ling, A. Zangarelli, J. Descoeur, F. Coudore, E. Bourinet, and A. Eschalier Animal models of chemotherapy-evoked painful peripheral neuropathies Neurotherapeutics 6 2009 620 629
158. K.D. Tanner, J.D. Levine, and K.S. Topp Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat J. Comp. Neurol. 395 1998 481 492 (Pubitemid 28226093)
159. K.S. Topp, K.D. Tanner, and J.D. Levine Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat J. Comp. Neurol. 424 2000 563 576 (Pubitemid 30643051)
160. S.J. Flatters, and G.J. Bennett Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction Pain 122 2006 245 257 (Pubitemid 43729476)
161. H.W. Jin, S.J. Flatters, W.H. Xiao, H.L. Mulhern, and G.J. Bennett Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells Exp. Neurol. 210 2008 229 237
162. G. Melli, M. Taiana, F. Camozzi, D. Triolo, P. Podini, A. Quattrini, F. Taroni, and G. Lauria Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy Exp. Neurol. 214 2008 276 284
163. T. Nakata, and H. Yorifuji Morphological evidence of the inhibitory effect of taxol on the fast axonal transport Neurosci. Res. 35 1999 113 122 (Pubitemid 29518402)
164. C. Theiss, and K. Meller Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro Cell Tissue Res. 299 2000 213 224 (Pubitemid 30103139)
165. S.C. Apfel Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors Cancer Investig. 18 2000 564 573 (Pubitemid 30485673)
166. S. Quasthoff, and H.P. Hartung Chemotherapy-induced peripheral neuropathy J. Neurol. 249 2002 9 17 (Pubitemid 34119018)
167. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl 2004 S18 S25
168. W.H. Xiao, F.Y. Zheng, G.J. Bennett, T. Bordet, and R.M. Pruss Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel Pain 147 2009 202 209
169. K.Y. Chan, and A.H. Bunt An association between mitochondria and microtubules in synaptosomes and axon terminals of cerebral cortex J. Neurocytol. 7 1978 137 143 (Pubitemid 8301219)
170. S.T. Brady, S.D. Crothers, C. Nosal, and W.O. McClure Fast axonal transport in the presence of high Ca2+: evidence that microtubules are not required Proc. Natl Acad. Sci. USA 77 1980 5909 5913 (Pubitemid 11211230)
171. S.T. Brady, R.J. Lasek, R.D. Allen, H.L. Yin, and T.P. Stossel Gelsolin inhibition of fast axonal transport indicates a requirement for actin microfilaments Nature 310 1984 56 58 (Pubitemid 14077861)
172. D.J. Goldberg Microinjection into an identified axon to study the mechanism of fast axonal transport Proc. Natl Acad. Sci. USA 79 1982 4818 4822
173. D.J. Goldberg, D.A. Harris, B.W. Lubit, and J.H. Schwartz Analysis of the mechanism of fast axonal transport by intracellular injection of potentially inhibitory macromolecules: evidence for a possible role of actin filaments Proc. Natl Acad. Sci. USA 77 1980 7448 7452 (Pubitemid 11131147)
174. R.L. Morris, and P.J. Hollenbeck Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons J. Cell Biol. 131 1995 1315 1326
175. D. Cartelli, C. Ronchi, M.G. Maggioni, S. Rodighiero, E. Giavini, and G. Cappelletti Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration J. Neurochem. 115 2010 247 258
176. M. Zheng, Q. Wang, Y. Teng, X. Wang, F. Wang, T. Chen, J. Samaj, J. Lin, and D.C. Logan The speed of mitochondrial movement is regulated by the cytoskeleton and myosin in Picea wilsonii pollen tubes Planta 231 2010 779 791
177. J.P. Dompierre, J.D. Godin, B.C. Charrin, F.P. Cordelieres, S.J. King, S. Humbert, and F. Saudou Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation J. Neurosci. 27 2007 3571 3583 (Pubitemid 46515140)
178. N.A. Reed, D. Cai, T.L. Blasius, G.T. Jih, E. Meyhofer, J. Gaertig, and K.J. Verhey Microtubule acetylation promotes kinesin-1 binding and transport Curr. Biol. 16 2006 2166 2172 (Pubitemid 44692098)
179. J. Zhou, M. Liu, R. Aneja, R. Chandra, and H.C. Joshi Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012 Biochem. Pharmacol. 68 2004 2435 2441 (Pubitemid 39535116)
180. S.H. Zhuang, Y.E. Hung, L. Hung, R.W. Robey, D.L. Sackett, W.M. Linehan, S.E. Bates, T. Fojo, and M.S. Poruchynsky Evidence for microtubule target engagement in tumors of patients receiving ixabepilone Clin. Cancer Res. 13 2007 7480 7486
181. I. Nennesmo, and F.P. Reinholt Effects of intraneural injection of taxol on retrograde axonal transport and morphology of corresponding nerve cell bodies Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 55 1988 241 246
182. J.W. Hammond, C.F. Huang, S. Kaech, C. Jacobson, G. Banker, and K.J. Verhey Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons Mol. Biol. Cell 21 2010 572 583
183. B. Trinczek, A. Ebneth, E.M. Mandelkow, and E. Mandelkow Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles J. Cell Sci. 112 Pt 14 1999 2355 2367 (Pubitemid 29381026)
184. J.C. Bulinski, T.E. McGraw, D. Gruber, H.L. Nguyen, and M.P. Sheetz Overexpression of MAP4 inhibits organelle motility and trafficking in vivo J. Cell Sci. 110 Pt 24 1997 3055 3064
185. A. Seitz, H. Kojima, K. Oiwa, E.M. Mandelkow, Y.H. Song, and E. Mandelkow Single-molecule investigation of the interference between kinesin, tau and MAP2c EMBO J. 21 2002 4896 4905
186. K. Nishio, H. Arioka, T. Ishida, H. Fukumoto, H. Kurokawa, M. Sata, M. Ohata, and N. Saijo Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel Int. J. Cancer 63 1995 688 693
187. J.R. Levy, C.J. Sumner, J.P. Caviston, M.K. Tokito, S. Ranganathan, L.A. Ligon, K.E. Wallace, B.H. LaMonte, G.G. Harmison, I. Puls, K.H. Fischbeck, and E.L. Holzbaur A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation J. Cell Biol. 172 2006 733 745
188. J. Jaworski, L.C. Kapitein, S.M. Gouveia, B.R. Dortland, P.S. Wulf, I. Grigoriev, P. Camera, S.A. Spangler, P. Di Stefano, J. Demmers, H. Krugers, P. Defilippi, A. Akhmanova, and C.C. Hoogenraad Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity Neuron 61 2009 85 100
189. O.A. Shemesh, and M.E. Spira Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy Acta Neuropathol. 119 2010 235 248
190. A.B. Knott, G. Perkins, R. Schwarzenbacher, and E. Bossy-Wetzel Mitochondrial fragmentation in neurodegeneration Nat. Rev. Neurosci. 9 2008 505 518 (Pubitemid 351873464)
191. A.B. Knott, and E. Bossy-Wetzel Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration Ann. NY Acad. Sci. 1147 2008 283 292
192. V. Voccoli, and L. Colombaioni Mitochondrial remodeling in differentiating neuroblasts Brain Res. 1252 2009 15 29
193. T. Shprung, and I. Gozes A novel method for analyzing mitochondrial movement: inhibition by paclitaxel in a pheochromocytoma cell model J. Mol. Neurosci. 37 2009 254 262
194. R. Yamaguchi, L. Lartigue, G. Perkins, R.T. Scott, A. Dixit, Y. Kushnareva, T. Kuwana, M.H. Ellisman, and D.D. Newmeyer Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization Mol. Cell 31 2008 557 569
195. M.S. Poruchynsky, P. Giannakakou, Y. Ward, J.C. Bulinski, W.G. Telford, R.W. Robey, and T. Fojo Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism Biochem. Pharmacol. 62 2001 1469 1480 (Pubitemid 33145290)